These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19867230)

  • 41. Induction of sister chromatid exchanges by BUdR is largely independent of the BUdR content of DNA.
    Davidson RL; Kaufman ER; Dougherty CP; Ouellette AM; DiFolco CM; Latt SA
    Nature; 1980 Mar; 284(5751):74-6. PubMed ID: 7354875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
    Andrews PW; Nudelman E; Hakomori S; Fenderson BA
    Differentiation; 1990 Apr; 43(2):131-8. PubMed ID: 2373286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Age specificity of the effect of 5-bromdeoxyuridine on the differentiation and spectra of chromosomal puffs in the salivary glands of Drosophila virilis Sturt. II. Alteration of the puff spectrum in salivary gland chromosomes].
    Poluéktova EV; Mitrofanov VG
    Genetika; 1977; 13(9):1596-604. PubMed ID: 598701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human in vivo antigen-induced lymphoblastoid B cells are capable of cyclical antibody production in vitro.
    Brieva JA; Stevens RH
    J Immunol; 1984 Jul; 133(1):147-53. PubMed ID: 6609972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
    Radner H; Kärcher H
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenic mechanism of 5-bromodeoxyuridine in Chinese hamster cells.
    Aebersold PM
    Mutat Res; 1976 Sep; 36(3):357-62. PubMed ID: 958231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Probing the interactions of the solvated electron with DNA by molecular dynamics simulations: II. bromodeoxyuridine-thymidine mismatched DNA.
    Gantchev TG; Hunting DJ
    J Mol Model; 2009 Jan; 15(1):9-23. PubMed ID: 18936988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients.
    Nishizaki T; Orita T; Kajiwara K; Ikeda N; Ohshita N; Nakayama H; Furutani Y; Ikeyama Y; Akimura T; Kamiryo T
    J Neurosurg; 1990 Sep; 73(3):396-400. PubMed ID: 1696625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of 5-bromodeoxyuridine on mouse embryos during neurulation in vitro.
    Nakashima K; Ninomiya H; Fujiki Y
    Experientia; 1984 Sep; 40(9):924-9. PubMed ID: 6468617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of endogenous guinea pig retrovirus by 5-bromodeoxyuridine: amplification of virus-specific RNA.
    Davis AR; Nayak DP; Lofgren J
    J Virol; 1978 Jun; 26(3):603-14. PubMed ID: 566798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil.
    Chelladurai M; Lobocki CA; Sultani M; Hanna Y; Drelichman A; Pieper DR; McLaughlin PW
    Cancer Chemother Pharmacol; 1997; 40(6):463-8. PubMed ID: 9332459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry.
    Danova M; Riccardi A; Gaetani P; Wilson GD; Mazzini G; Brugnatelli S; Buttini R; Butti G; Ucci G; Paoletti P
    Eur J Cancer Clin Oncol; 1988 May; 24(5):873-80. PubMed ID: 3169092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-bromodeoxyuridine monoclonal antibody: an alternative tool for the identification of replicated DNA at the electron microscope level.
    Thiry M; Dombrowicz D
    Biol Cell; 1988; 62(1):99-102. PubMed ID: 2966644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Silver-staining specificity in metaphases after incorporation of 5-bromodeoxyuridine (BUDR).
    Vogel W; Schempp W; Puel V
    Hum Genet; 1978 Jan; 40(2):199-203. PubMed ID: 75162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
    Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
    Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibody Ki-67 as a marker of proliferative activity in monoclonal gammopathies.
    Girino M; Riccardi A; Luoni R; Ucci G; Cuomo A
    Acta Haematol; 1991; 85(1):26-30. PubMed ID: 2011926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of rat myosin light-chain synthesis in heterokaryons between 5-bromodeoxyuridine-blocked rat myoblasts and differentiated chick myocytes.
    Wright WE; Aronoff J
    J Cell Biol; 1983 Jun; 96(6):1571-9. PubMed ID: 6853595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR).
    Mitchell JB; Kinsella TJ; Russo A; McPherson S; Rowland J; Smith BH; Kornblith PL; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):457-63. PubMed ID: 6303991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of bromodeoxyuridine uptake and MIB 1 immunoreactivity in medulloblastomas determined with single and double immunohistochemical staining methods.
    Onda K; Davis RL; Edwards MS
    J Neurooncol; 1996 Aug; 29(2):129-36. PubMed ID: 8858517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Dionigi P; Gaetani P; Cebrelli T; Butti G; Mazzini G; Wilson G
    Br J Cancer; 1989 Jun; 59(6):898-903. PubMed ID: 2736227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.